乳腺癌患者心房颤动发病危险因素分析
Analysis of Risk Factors for Atrial Fibrillation Onset in Breast Cancer Patients
摘要: 目的：探讨乳腺癌患者心房颤动发病的危险因素。方法：回顾性收集2022年1月至2022年12月确诊为乳腺癌的患者342例临床资料，根据心电图诊断依据分为心房颤动组与窦性心律组，采用卡方检验对分类变量危险因素进行分析，采用logistic回归模型对连续变量危险因素进行分析。结果：年龄、HER-2阳性、Ki-67阴性、低镁血症与乳腺癌患者房颤的发生存在密切关联。
Abstract: Objective: To explore the risk factors for atrial fibrillation onset in breast cancer patients. Methods: Clinical data of 342 patients diagnosed with breast cancer from January 2022 to December 2022 were retrospectively collected. Patients were divided into atrial fibrillation group and sinus rhythm group based on electrocardiogram diagnosis. Chi-square test was used to analyze categorical variable risk factors, and logistic regression model was used to analyze continuous variable risk factors. Results: Age, HER-2 positivity, Ki-67 negativity and hypomagnesemia were closely associated with the occurrence of atrial fibrillation in breast cancer patients.
文章引用：汤怀广, 孙裕, 李宾公. 乳腺癌患者心房颤动发病危险因素分析[J]. 临床医学进展, 2024, 14(3): 1998-2004. https://doi.org/10.12677/acm.2024.143935

参考文献

[1] Siegel, R.L., Miller, K.D., Wagle, N.S. and Jemal, A. (2023) Cancer Statistics, 2023. Ca-A Cancer Journal for Clinicians, 73, 17-48. [Google Scholar] [CrossRef] [PubMed]
[2] Huang, J., Chan, P.S., Lok, V., Chen, X., Ding, H., Jin, Y., Yuan, J., Lao, X.Q., Zheng, Z.J. and Wong, M.C. (2021) Global Incidence and Mortality of Breast Cancer: A Trend Analysis. Aging (Albany NY), 13, 5748-5803. [Google Scholar] [CrossRef] [PubMed]
[3] Galimzhanov, A., Istanbuly, S., Tun, H.N., Ozbay, B., Alasnag, M., Ky, B., Lyon, A.R., Kayikcioglu, M., Tenekecioglu, E., Panagioti, M., et al. (2023) Cardiovascular Outcomes in Breast Cancer Survivors: A Systematic Review and Meta-Analysis. European Journal of Preventive Cardiology, 30, 2018-2031. [Google Scholar] [CrossRef] [PubMed]
[4] Yang, H., Bhoo-Pathy, N., Brand, J.S., Hedayati, E., Grassmann, F., Zeng, E., Bergh, J., Bian, W., Ludvigsson, J.F., Hall, P., et al. (2022) Risk of Heart Disease Following Treatment for Breast Cancer: Results from a Population-Based Cohort Study. Elife, 11, e71562. [Google Scholar] [CrossRef] 
[5] Zimetbaum, P. (2017) Atrial Fibrillation. Annals of Internal Medicine, 166, ITC33-ITC48. [Google Scholar] [CrossRef] 
[6] Jakobsen, C.B., Lamberts, M., Carlson, N., Lock-Hansen, M., Torp-Pedersen, C., Gislason, G.H. and Schou, M. (2019) Incidence of Atrial Fibrillation in Different Major Cancer Subtypes: A Nationwide Population-Based 12 Year Follow Up Study. BMC Cancer, 19, 1105. [Google Scholar] [CrossRef] [PubMed]
[7] Higuchi, S., Kabeya, Y., Matsushita, K., Arai, N., Tachibana, K., Tanaka, R., Kawachi, R., Takei, H., Suzuki, Y., Kogure, M., et al. (2019) Incidence and Complications of Perioperative Atrial Fibrillation after Non-Cardiac Surgery for Malignancy. PLOS ONE, 14, E0216239. [Google Scholar] [CrossRef] [PubMed]
[8] Abdel-Qadir, H., Thavendiranathan, P., Fung, K., Amir, E., Austin, P.C., Anderson, G.S. and Lee, D.S. (2019) Association of Early-Stage Breast Cancer and Subsequent Chemotherapy with Risk of Atrial Fibrillation. JAMA Network Open, 2, E1911838. [Google Scholar] [CrossRef] [PubMed]
[9] Beck, R.E., Kim, L., Yue, N.J., Haffty, B.G., Khan, A.J. and Goyal, S. (2014) Treatment Techniques to Reduce Cardiac Irradiation for Breast Cancer Patients Treated with Breast-Conserving Surgery and Radiation Therapy: A Review. Frontiers in Oncology, 4, 327. [Google Scholar] [CrossRef] [PubMed]
[10] Guha, A., Fradley, M.G., Dent, S.F., Weintraub, N.L., Lustberg, M.B., Alonso, A. and Addison, D. (2022) Incidence, Risk Factors, and Mortality of Atrial Fibrillation in Breast Cancer: A Seer-Medicare Analysis. European Heart Journal, 43, 300-312. [Google Scholar] [CrossRef] [PubMed]
[11] Shalapour, S. and Karin, M. (2019) Pas De Deux: Control of Anti-Tumor Immunity by Cancer-Associated Inflammation. Immunity, 51, 15-26. [Google Scholar] [CrossRef] [PubMed]
[12] Aviles, R.J., Martin, D.O., Apperson-Hansen, C., Houghtaling, P.L., Rautaharju, P., Kronmal, R.A., Tracy, R.P., Van Wagoner, D.R., Psaty, B.M., Lauer, M.S., et al. (2003) Inflammation as a Risk Factor for Atrial Fibrillation. Circulation, 108, 3006-3010. [Google Scholar] [CrossRef] 
[13] Andersson, T.M., Rutherford, M.J. and Humphreys, K. (2017) Assessment of Lead-Time Bias in Estimates of Relative Survival for Breast Cancer. Cancer Epidemiology, 46, 50-56. [Google Scholar] [CrossRef] [PubMed]
[14] Moturi, S., Rao, S.N.T. and Vemuru, S. (2021) Grey Wolf Assisted Dragonfly-Based Weighted Rule Generation for Predicting Heart Disease and Breast Cancer. Computerized Medical Imaging and Graphics, 91, Article ID 101936. [Google Scholar] [CrossRef] [PubMed]
[15] Linz, D., Gawalko, M., Betz, K., Hendriks, J.M., Lip, G.Y.H., Vinter, N., Guo, Y. and Johnsen, S. (2024) Atrial Fibrillation: Epidemiology, Screening and Digital Health. The Lancet Regional Health-Europe, 37, Article ID 100786. [Google Scholar] [CrossRef] [PubMed]
[16] Jame, S. and Barnes, G. (2020) Stroke and Thromboembolism Prevention in Atrial Fibrillation. Heart, 106, 10-17. [Google Scholar] [CrossRef] [PubMed]
[17] Joglar, J.A., Chung, M.K., Armbruster, A.L., Benjamin, E.J., Chyou, J.Y., Cronin, E.M., Deswal, A., Eckhardt, L.L., Goldberger, Z.D., Gopinathannair, R., et al. (2024) 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of The American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 149, E1-E156. [Google Scholar] [CrossRef] 
[18] Beral, V., Banks, E., Reeves, G. and Bull, D. (On Behalf of the Million Women Study Collaborator) (2003) Breast Cancer and Hormone-Replacement Therapy in the Million Women Study. Lancet, 362, 419-427. [Google Scholar] [CrossRef] 
[19] January, C.T., Wann, L.S., Alpert, J.S., Calkins, H., Cigarroa, J.E., Cleveland Jr., J.C., Conti, J.B., Ellinor, P.T., Ezekowitz, M.D., Field, M.E., et al. (2014) 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation: Executive Summary: A Report of The American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Heart Rhythm Society. Circulation, 130, 2071-2104. [Google Scholar] [CrossRef] 
[20] Nalliah, C.J., Bell, J.R., Raaijmakers, A.J.A., Waddell, H.M., Wells, S.P., Bernasochi, G.B., Montgomery, M.K., Binny, S., Watts, T., Joshi, S.B., et al. (2020) Epicardial Adipose Tissue Accumulation Confers Atrial Conduction Abnormality. Journal of the American College of Cardiology, 76, 1197-1211. [Google Scholar] [CrossRef] [PubMed]
[21] Venteclef, N., Guglielmi, V., Balse, E., Gaborit, B., Cotillard, A., Atassi, F., Amour, J., Leprince, P., Dutour, A., Clement, K., et al. (2015) Human Epicardial Adipose Tissue Induces Fibrosis of the Atrial Myocardium through the Secretion of Adipo-Fibrokines. European Heart Journal, 36, 795-805. [Google Scholar] [CrossRef] [PubMed]
[22] Mazurek, T., Zhang, L., Zalewski, A., Mannion, J.D., Diehl, J.T., Arafat, H., Sarov-Blat, L., O’Brien, S., Keiper, E.A., Johnson, A.G., et al. (2003) Human Epicardial Adipose Tissue Is a Source of Inflammatory Mediators. Circulation, 108, 2460-2466. [Google Scholar] [CrossRef] 
[23] Darby, S.C., Ewertz, M., McGale, P., Bennet, A.M., Blom-Goldman, U., Brønnum, D., Correa, C., Cutter, D., Gagliardi, G., Gigante, B., et al. (2013) Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer. The New England Journal of Medicine, 368, 987-998. [Google Scholar] [CrossRef] 
[24] Meattini, I., Poortmans, P.M., Aznar, M.C., Becherini, C., Bonzano, E., Cardinale, D., Lenihan, D.J., Marrazzo, L., Curigliano, G. and Livi, L. (2021) Association of Breast Cancer Irradiation with Cardiac Toxic Effects: A Narrative Review. JAMA Oncology, 7, 924-932. [Google Scholar] [CrossRef] [PubMed]

为你推荐